Covidien Introduces First FDA-Approved Spine Sealant

"Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM) spine sealant, the first product approved by the FDA for intra-operative sealing of the dural membrane during spine procedures." (Photo: Business Wire)

View Full Size

Download

Thumbnail JPEG, 53x72, 2.0 KB
Preview JPEG, 107x144, 4.4 KB
Small JPEG, 225x300, 13.6 KB
Full Size JPEG, 1500x2000, 869.4 KB

Smart Multimedia Gallery

"Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM) spine sealant, the first product approved by the FDA for intra-operative sealing of the dural membrane during spine procedures."

Play and Share Video

"Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM) spine sealant, the first product approved by the FDA for intra-operative sealing of the dural membrane during spine procedures." (Photo: Business Wire)